| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2874285 | The Annals of Thoracic Surgery | 2013 | 8 Pages |
Abstract
Administration of sivelestat during bypass prevented pulmonary damage and activities of proinflammatory cytokines at the cardiac operation in neonates or infants. Our results show that sivelestat may be considered to protect pulmonary function against the injury by bypass.
Keywords
CPBICAM-1ELAM-1VSDPMNCK-MBPao2/Fio2Qp/Qsinterleukincardiopulmonary bypassICUintensive care unitanalysis of varianceANOVAalveolar-arterial oxygen tension gradientintercellular adhesion molecule-1endothelial leukocyte adhesion molecule-1Ventricular septal defectPulmonary hypertensionPolymorphonuclearcreatine kinase-myocardial band
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Norikazu MD, PhD, Miki MD, PhD, Takayuki MD, PhD, Takuya MD, PhD, Akira MD, PhD,